ArticleFrontiers in oncology2026
Preoperative phenotypic stratification of primary central nervous system lymphoma using multiparametric MRI-based radiomics: prediction of germinal center B-cell-like and double-expression status.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary central nervous system lymphoma (PCNSL) exhibits substantial biological heterogeneity, particularly across immunohistochemical subtypes such as double-expression lymphoma (DEL) and germinal center B-cell-like (GCB) phenotypes. This study aimed to develop and evaluate multiparametric MRI-based radiomics models for preoperative prediction of DEL andGCB status in PCNSL. Methods: We retrospectively included 160 pathologically confirmed PCNSL patients. Multiparametric MRI sequences, including T2-weighted (T2WI), T2-Fluid-Attenuated Inversion Recovery (FLAIR), contrast-enhanced T1-weighted (T1CE), and apparent diffusion coefficient (ADC), were analyzed. Enhancing tumor core and peritumoral edema were automatically segmented using nnU-NetV2-based models, and radiomics features were extracted from both regions across all sequences. After reproducibility filtering, ComBat harmonization, and multistep feature selection performed exclusively within the training cohort, six machine-learning classifiers were trained and evaluated in held-out internal test sets. Model performance was assessed using ROC and decision curve analysis, and SHAP-based feature interpretation. Results: For DEL classification, 12 radiomic features were retained. The SVM classifier achieved the best test performance, with an area under the ROC curve (AUC) of 0.807 (95% CI, 0.649-0.936), accuracy of 0.730, sensitivity of 0.714, and specificity of 0.750. For GCB/non-GCB classification, seven radiomic features were used for model construction. The Random Forest classifier achieved the highest test performance, with an AUC of 0.897 (95% CI, 0.796-0.973), accuracy of 0.846, sensitivity of 0.792, and specificity of 0.893. Conclusions: Multiparametric MRI-based radiomics analysis demonstrated promising performance for noninvasive prediction of DEL and GCB/non-GCB phenotypes in PCNSL. These findings suggest that MRI-derived radiomic features may capture imaging correlates of biological heterogeneity and may support preoperative risk stratification and individualized treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.